Original Research
Published on 05 Feb 2021
Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment
in Pediatric Hematology and Hematological Malignancies
Frontiers in Pediatrics
doi 10.3389/fped.2020.614521
- 6,225 views
- 8 citations
